Two of this month's five free Independent AI Audits are still open, included when you start an AI health check.Check eligibility →
For the board

The board's assurance is only as good as the report behind it.

Is the business plan ready for an AI world?

The board needs to decide where AI changes the plan, what to invest in and who will deliver it. We help connect strategy, skills, organisational design, risk and measurable progress.

66%

of boards have limited or no knowledge of AI, and 31% do not have it on the agenda.

Deloitte, Governance of AI, 2025
1 Jan 2026

the date from which listed companies must declare how effective their material controls are, under Provision 29 of the UK Corporate Governance Code.

Financial Reporting Council, 2024 Code
63% / 13%

of organisations whose boards discuss AI at every meeting are high-return, against organisations that rarely do (consultancy survey: an association, not proof).

Protiviti, 2026
What you are carrying

Six things a director is accountable for and finds hard to see.

66%

of boards have limited or no knowledge of AI, according to Deloitte's 2025 research.

Deloitte, Governance of AI, 2025
"All I see is management's assurance."

Reports describe intent, not behaviour. What it costs you: you cannot test the assurance you are relying on.

"I do not know which questions to ask."

Directors are not expected to be technical. They are expected to ask. What it costs you: a discussion that stays at the level of enthusiasm or fear.

"AI is a slide in the strategy deck."

A strategy page with nothing behind it fails at the first follow-up. What it costs you: an answer that falls apart when a regulator or insurer asks further.

"Do our AI controls count as material controls?"

Listed companies must now declare the effectiveness of controls that matter most to long-term sustainability, and say where they failed. Others increasingly follow this as good practice. What it costs you: a declaration you cannot support for the AI you use.

"The insurer is asking for evidence at renewal."

Insurers have started to ask for an AI policy, framework, training and monitoring evidence (Lockton, reported in Legal Futures, March 2026). What it costs you: terms, price or cover.

"We have spent, and cannot say what we got."

56% of chief executives report no significant financial benefit from AI (PwC, 2026). What it costs you: investment approved on hope, with no measure to stop or scale it.

A different way to look at it

The board does not govern the technology. It governs five questions, asked regularly.

What AI is in use? Who owns each use? What does it cost and return? Which rules apply, and are they followed? What evidence exists? A board that asks these five questions every quarter, and receives the same one-page answer each time, is doing the job. The document matters less than the rhythm. Boards that discuss AI regularly are associated with better returns, though that is an association, not proof. The practical aim is a report that management can produce without a project each time.

Association from Protiviti (2026, consultancy survey). Not proof of cause.

How GenWA helps

Six things that give a board a report it can rely on.

Board Report, Usage Insight, Register and Value Register are in early access. Evidence Packs and Compliance Mapping are available. We confirm in writing what you receive.

Where to start

Three moves for the chair and the audit and risk committee.

Step 1Ask management for the five answers: what is in use, who owns it, what it costs and returns, which rules apply, what evidence exists.
Step 2Ask management to run the AI health check, and for a summary the board can read in one sitting.
Step 3Agree the rhythm. Decide how often the board sees the report, and which measures it wants to see move.
Ways of working with us

Three routes, matched to what a board commissions.

Bring them with you

The three executives the board will rely on.

Public regulator action

A leisure operator was told to stop using facial recognition to monitor staff.

In 2024 the Information Commissioner's Office ordered Serco Leisure and related companies to stop using facial recognition and fingerprint scanning to monitor the attendance of more than 2,000 staff, and to delete the data. There was no AI-specific fine. The point for directors is that the risk needed to be assessed before the system was switched on, and the board could have asked for that assessment.

ICO enforcement notice, February 2024. Public regulator action. GenWA had no involvement.

Want to see the board view?

Book a demo and we will walk through a board report built from example data.

Insights

Keep reading

Five priorities for 2026
  • A business plan that has not been tested against AI change
  • Investment choices without a costed route to value
  • Management reports that describe activity rather than outcomes
  • Unclear accountability for skills, agents and consequential decisions
  • An organisation structure designed for yesterday’s work
Opportunities to prepare for in 2027
  • Review the plan and prioritise AI investments by evidence
  • Test scenarios before making capital commitments
  • Receive a regular board pack on costs, outcomes and risks
  • Agree the people, skills and oversight needed for delivery
  • Challenge progress against milestones and time to value
A plan grounded in your business

The board needs to decide where AI changes the plan, what to invest in and who will deliver it. We help connect strategy, skills, organisational design, risk and measurable progress.

Find out more

Starting figures are examples. Edit the assumptions for your own work. This estimates released capacity, not guaranteed cash savings.

Questions we are asked

Straight answers.

What should a board ask about AI?

Ask what AI is in use, who owns each use, what it costs and returns, which rules apply and whether they are followed, and what evidence exists. Ask for the same one-page answer each time so movement is visible. Board Report is built to produce that page on a regular cycle.

What is the AI Effectiveness Index?

A score across adoption, control, efficiency and return, calculated from your own answers and data. The method is explained in the audit so the board can test it against its own questions. It is a management tool, not a certification or an assurance.

Is AI governance a board matter or a management matter?

Management runs it. The board decides what to ask for and how often. Deloitte's 2025 research found 66% of boards have limited or no AI knowledge, so a short, regular report helps directors do their part without becoming technical experts.

Does Provision 29 of the Corporate Governance Code apply to AI?

Provision 29 applies to listed companies for financial years starting on or after 1 January 2026. It requires a declaration on the effectiveness of material controls. Whether AI controls are material is the board's judgement. Other organisations often use it as good practice. Take legal advice.

Can we trust a vendor's own index?

It is calculated from your answers and data, and the method is explained so you can test it. It is not a certification. For independent assurance on your controls, use accredited bodies. We prepare evidence; certification is issued by accredited bodies.

What evidence can the board show an insurer or regulator?

Evidence Packs contain the register, data-flow map, control matrix and exception log, control-mapped to ISO/IEC 42001, UK GDPR and the 2025 Act, SOC 2 and Cyber Essentials. The insurer or regulator decides what is sufficient. This supports compliance and is not legal advice.

How does a board get started?

Ask management to run the AI health check, using the questionnaire, a usage-export check or a visit. The board then sees one summary of use, cost, control and next steps. Advice, product or an agent function we run for you can follow, if the board chooses.

How do we choose the first AI investment?

Review the plan and prioritise AI investments by evidence. We start with the problem, the accountable owner and a baseline. Agree a small scope, the cost of delivery and a measurable test before scaling.

How should we measure time to value?

Measure the elapsed time from an agreed start to the first accepted business outcome. Include setup, integration, human review and rework. A faster prototype is useful, but it is not the same as a result your business can use.

How does GenWA work with our team?

Choose the support you need: advice, modules, a scoped build, incubation or acceleration. We can build and run alongside your team. Your named people retain supervision and consequential decisions. Scope, fees, hosting and any outcome-based arrangements are agreed in writing.

Research behind these priorities

The five priorities are GenWA’s editorial selection, informed by the sources below and your role. The 2027 opportunities are planning scenarios, not a survey ranking or forecast.